From Gomerpedia
Jump to: navigation, search
Monoclonal antibodies.svg

Futilimab is a monoclonal antibody indicated in the treatment of metastatic cancer complicated by septic shock, multi-organ system failure, and death.[1] The drug costs about $4,000,000,000 per infusion, is infused rectally over 35 days, and extends life-expectancy by an average of 3 minutes. When used with hospicillin, the effects of futilimab are synergistic.

Related Topics


  1. Oncologist Puts Dying Ficus Tree on Palliative Chemo (Gomerblog)

Fun Stuff

Try a random entry.
Push me button.jpg
this post with your friends

Random Gomerpedia Entries

Need More Gomer?